Yu, J., Bai, G., Li, M., Wang, T., Zhao, Z., Wang, X., Li, H., Yang, Q., Pan, Y., Jiang, Z., Liu, N., Lv, Z., Wang, Y., Wang, L., Sun, H., Wang, Q., Zhang, X., Lai, W., Yong, J., Hao, J. (2026). GK01 stemness-enriched tumor-reactive T-cell therapy plus IL-2 in advanced solid tumors: ORR and clonal persistence results in a first-in-human phase I study (GUARDIAN-01).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2540